भारतीय भेषज संहिता आयोग
Summary on Training conducted byIPC from 01 April, 2014 to 19 June 2015
News & Highlights
- Suspected Adverse Drug Reaction Reporting Form(For Drugs Used In Prophylaxis/Treatment Of Covid-19)
- Draft version of NFI, 6th edition for Stakeholder/public comments. Last date for receiving comments at IPC: 20 June 2020
- IPC Office Order dated 18.05.2020
- IPC Office Order dated 04.05.2020 for Regular/Contractual/Outsourced Staff of IPC
- MHA Order dt 01.05.2020, with New Guidelines
- IPC Office Memorandum No. IPC/1064/2020-21 for effective use of ‘Aarogyasetu’ app for breaking the chain of transmission of COVID-19.
- Stakeholder’s comments/suggestions are invited to the draft of monograph for 1. Patha, 2. Seena powder microscopy
- IPC Office-Memorandum dated 17.04.2020
- MHA Order dt 15.04.2020, with Revised Consolidated Guidelines
- Notice to all the Stakeholders of IPC due to Novel Coronavirus Disease (COVID-19)
- COVID-19 Updates
- Corrigendum for amendment list-004 to IP 2018
- Advisory for Reporting ADRs due to Hydroxychloroquine in COVID-19
- Postponement of Workshop-cum-Training Programme on Pharmacovigilance for NABH Accredited Hospitals of Chennai region scheduled on 8th April 2020, at Department of Pharmacology, Govt. Stanley Medical College, Chennai
- Postponement of 15th Skill Development Programme on Pharmacovigilance for Medical Products scheduled on 23-27 March 2020 at IPC, Ghaziabad has been postponed due to the Novel Coronavirus (COVID-19) outbreak till further notice.
- Workshop-cum-Training Programme on Pharmacovigilance for NABH Accredited Hospitals of Chennai region on 8th April 2020, at Department of Pharmacology, Govt. Stanley Medical College, Chennai.
- Notice on Postponed Meeting of ‘Expert working group along with Stakeholders -Veterinary Biologicals’ on 23rdMarch 2020 and ‘Expert working group along with Stakeholders Veterinary pharmaceuticals’ on 24th March 2020 at IPC, Ghaziabad
- Circular on Postpone of "Promoting medical devices safety & surveillance in India - Stakeholders summit" at India Habitat Centre on March 20, 2020
- Notice on Postponed of one day Awareness Programme on IP and IPRS on 18 March 2020 at Dheradun
- Notice for Compliance of IP, IP Addendum and Amendment list
- Amendment list 004 to IP-2018
- Indian Pharmacopoeia Commission has newly added 19 system suitability/Quantitative impurities for the use of stakeholders
- PT Schedule 2020
- Press Release on Inauguration of 6th Asia-Pacific Pharmacovigilance Training Course
- Four Days (04) Training Programme on NABL Accreditation as per ISO/IEC/ 17025:2017 for Government Officials of Central, State and Regional Drugs Testing Laboratories from 10th to 13th February, 2020
- PvPI Training Calender 2020
- Release of Annual Report 2018-19 of IPC and Annual Performance Report 2018-19 of Pharmacovigilance Programme of India (PvPI) at Nirman Bhawan, New Delhi on 21.01.2020
- One Day Workshop on awareness of Indian Pharmacopoeia (IP) and Indian Pharmacopoeia Reference Standards (IPRS) at Dehradun on 18th March 2020
- Skill Development Programme on Pharmacovigilance for Medical Products (PvM)- 2020
- Skill Development Programme on Pharmacovigilance for Medical Products (PvM)- 2020
View All
